These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 27032563)
1. In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system. Peruzynska M; Szelag S; Trzeciak K; Kurzawski M; Cendrowski K; Barylak M; Roginska D; Piotrowska K; Mijowska E; Drozdzik M Int J Pharm; 2016 Jun; 506(1-2):458-68. PubMed ID: 27032563 [TBL] [Abstract][Full Text] [Related]
2. Sandwich-like mesoporous silica flakes for anticancer drug transport-Synthesis, characterization and kinetics release study. Mijowska E; Cendrowski K; Barylak M; Konicki W Colloids Surf B Biointerfaces; 2015 Dec; 136():119-25. PubMed ID: 26381695 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254 [TBL] [Abstract][Full Text] [Related]
4. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect. Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925 [TBL] [Abstract][Full Text] [Related]
5. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis. Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884 [TBL] [Abstract][Full Text] [Related]
6. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563 [TBL] [Abstract][Full Text] [Related]
7. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect. Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539 [TBL] [Abstract][Full Text] [Related]
8. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo. Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133 [TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638 [TBL] [Abstract][Full Text] [Related]
11. Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers. Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Boyd BJ; Owen DJ; Porter CJ Mol Pharm; 2011 Apr; 8(2):338-49. PubMed ID: 21171585 [TBL] [Abstract][Full Text] [Related]
12. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment. Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075 [TBL] [Abstract][Full Text] [Related]
15. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies. Jin Y; Lian Y; Du L; Wang S; Su C; Gao C Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963 [TBL] [Abstract][Full Text] [Related]
16. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures. Chen Y; Chen H; Shi J Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014 [TBL] [Abstract][Full Text] [Related]
17. [PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents]. Kong SY; Tang GT; Pei YY; Jiang YY Yao Xue Xue Bao; 2009 Jan; 44(1):85-90. PubMed ID: 19350828 [TBL] [Abstract][Full Text] [Related]
18. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer. Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153 [TBL] [Abstract][Full Text] [Related]
19. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate. Salehi R; Rasouli S; Hamishehkar H Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723 [TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Efficacy of a Novel Glucose-Methotrexate Conjugate in Targeted Cancer Treatment. Woźniak M; Pastuch-Gawołek G; Makuch S; Wiśniewski J; Krenács T; Hamar P; Gamian A; Szeja W; Szkudlarek D; Krawczyk M; Agrawal S Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]